SpartaLabs
June 17, 2026
Tesamorelin: Discovery and Regulatory History
A chronological account of tesamorelin's development — from the isolation of endogenous GHRH in 1982 through Theratechnologies' clinical program, FDA approval of Egrifta in 2010, and continued research through 2025. Educational reference.
tesamorelinghrh-analogregulatory-history